Huda Y Zoghbi insider trades

Open-market stock purchases and sales by Huda Y Zoghbi, Director at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 9, 2016.

Recent trades

DateStockTradeValue
Aug 10, 2026REGN Regeneron Pharmaceuticals, IncSold$640K
Aug 10, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$172K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$126K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$44K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$3.2K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$38K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$38.8K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$41.3K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$162K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$258K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$163K
Feb 19, 2026REGN Regeneron Pharmaceuticals, IncSold$233K
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—

Companies traded

  • REGN Regeneron Pharmaceuticals, Inc: 34 sales, last Aug 10, 2026

Get free alerts when Huda Y Zoghbi files a new trade →